Mucosal immunization of BALB/c mice using enterotoxigenic Escherichia coli colonization factors CFA/I and CS6 administered with and without a mutant heat-labile enterotoxin

被引:19
作者
Byrd, W [1 ]
Cassels, FJ [1 ]
机构
[1] Walter Reed Army Inst Res, Dept Enter Infect, Silver Spring, MD 20910 USA
关键词
enterotoxigenic Escherichia coli (ETEC); colonization factors (CFA/I and CS6); mutant heat-labile enterotoxin LT(R192G) (mLT);
D O I
10.1016/S0264-410X(03)00014-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mice (BALB/c) were intranasally (IN) and intragastrically (IG) administered the ETEC colonization factors (CF), CFA/I and CS6, with and without the R192G mutant heat-labile enterotoxin (mLT), and immunogenicity and efficacy measured. The IN administration of CFA/I to mice induced strong serum and fecal IgG and IgA responses. The IG administration of CFA/I to mice induced serum IgG and fecal IgA responses, but only when mLT was co-administered with CFA/I were serum IgA titers detected. The IN administration of CS6 to mice induced serum IgG antibodies, and mLT, when co-administered with CS6, enhanced the serum IgG response. Only when the mLT was co-administered with CS6, were serum and fecal IgA responses detected. The IG administration of CS6 plus mLT induced serum IgG and fecal IgA responses. Partial protection against lethal challenge with ETEC strain H10407 was seen in the mice IN administered the CFA/I plus mLT (P < 0.01), and H10407 was cleared from the lungs of CFA/I plus mLT-immunized mice at a significantly greater rate than from the control mice (P < 0.05). CFA/I and CS6 administered IN and IG induced mixed Th1/Th2 immune responses with the Th2 type being predominant as evidenced by IgG1 > IgG2a. The administration of colonization factors to mice, particularly by the IN route, potentially serves as a useful way to measure the serum and mucosal immune responses to these antigens prior to their use in volunteers. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1884 / 1893
页数:10
相关论文
共 47 条
[1]   INTESTINAL ANTIBODY-RESPONSE AFTER ORAL IMMUNIZATION WITH A PROTOTYPE CHOLERA-B SUBUNIT - COLONIZATION FACTOR ANTIGEN ENTEROTOXIGENIC ESCHERICHIA-COLI VACCINE [J].
AHREN, C ;
WENNERAS, C ;
HOLMGREN, J ;
SVENNERHOLM, AM .
VACCINE, 1993, 11 (09) :929-934
[2]   AN ADJUVANT FORMULATION THAT SELECTIVELY ELICITS THE FORMATION OF ANTIBODIES OF PROTECTIVE ISOTYPES AND OF CELL-MEDIATED-IMMUNITY [J].
ALLISON, AC ;
BYARS, NE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (02) :157-168
[3]  
[Anonymous], 1999, MUCOSAL IMMUNOL
[4]   Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity [J].
Baqar, S ;
Bourgeois, AL ;
Applebee, LA ;
Mourad, AS ;
Kleinosky, MT ;
Mohran, Z ;
Murphy, JR .
INFECTION AND IMMUNITY, 1996, 64 (12) :4933-4939
[5]  
BIENENSTOCK J, 1999, MUCOSAL IMMUNOLOGY, P283
[6]  
BLACK RE, 1986, DEV VACCINES DRUGS D, P23
[7]  
BLACK RE, 1990, REV INFECT DIS, V12, P73
[8]  
BOURGUIGNON P, 1999, MOL APPROACHES VACCI, P23
[9]   Pathogenicity and immune response measured in mice following intranasal challenge with enterotoxigenic Escherichia coli strains H10407 and B7A [J].
Byrd, W ;
Mog, SR ;
Cassels, FJ .
INFECTION AND IMMUNITY, 2003, 71 (01) :13-21
[10]   COLONIZATION FACTORS OF DIARRHEAGENIC ESCHERICHIA-COLI AND THEIR INTESTINAL RECEPTORS [J].
CASSELS, FJ ;
WOLF, MK .
JOURNAL OF INDUSTRIAL MICROBIOLOGY, 1995, 15 (03) :214-226